Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Cavalli

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Pharmacology|November 22, 2018
Anakinra Therapy for Non-cancer Inflammatory DiseasesGiulio Cavalli, Charles A Dinarello
Annals of Translational Medicine|January 8, 2019
Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factorsGiulio Cavalli, Ennio Giulio Favalli
Expert Review of Clinical Immunology|October 31, 2019
Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritisGiulio Cavalli, Ennio Giulio Favalli
Rheumatology (Oxford, England)|July 26, 2015
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesGiulio Cavalli, Charles A Dinarello
Immunological Reviews|December 17, 2017
Suppression of inflammation and acquired immunity by IL-37Giulio Cavalli, Charles A Dinarello
Frontiers in Pharmacology|March 26, 2019
Corrigendum: Anakinra Therapy for Non-cancer Inflammatory DiseasesGiulio Cavalli, Charles A Dinarello
European Journal of Internal Medicine|July 16, 2014
An enlightening scanLorenzo Canziani, Alessandro Tomelleri, Giulio Cavalli
Rheumatology (Oxford, England)|March 22, 2021
The choice of early treatment and the impact of future relapses in adult onset Still's diseaseCorrado Campochiaro, Giulio Cavalli, Lorenzo Dagna
British Journal of Haematology|June 10, 2014
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpuraGiulio Cavalli, Claudio Sallemi, Alvise Berti
Rheumatology (Oxford, England)|September 24, 2021
In the limelight: AA amyloidosis exposes TNF receptor-1 associated periodic syndromeGiulio Cavalli, Corrado Campochiaro, Lorenzo Dagna
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Pharmacology|November 22, 2018
Anakinra Therapy for Non-cancer Inflammatory DiseasesGiulio Cavalli, Charles A Dinarello
Annals of Translational Medicine|January 8, 2019
Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factorsGiulio Cavalli, Ennio Giulio Favalli
Expert Review of Clinical Immunology|October 31, 2019
Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritisGiulio Cavalli, Ennio Giulio Favalli
Rheumatology (Oxford, England)|July 26, 2015
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesGiulio Cavalli, Charles A Dinarello
Immunological Reviews|December 17, 2017
Suppression of inflammation and acquired immunity by IL-37Giulio Cavalli, Charles A Dinarello
Frontiers in Pharmacology|March 26, 2019
Corrigendum: Anakinra Therapy for Non-cancer Inflammatory DiseasesGiulio Cavalli, Charles A Dinarello
European Journal of Internal Medicine|July 16, 2014
An enlightening scanLorenzo Canziani, Alessandro Tomelleri, Giulio Cavalli
Rheumatology (Oxford, England)|March 22, 2021
The choice of early treatment and the impact of future relapses in adult onset Still's diseaseCorrado Campochiaro, Giulio Cavalli, Lorenzo Dagna
British Journal of Haematology|June 10, 2014
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpuraGiulio Cavalli, Claudio Sallemi, Alvise Berti
Rheumatology (Oxford, England)|September 24, 2021
In the limelight: AA amyloidosis exposes TNF receptor-1 associated periodic syndromeGiulio Cavalli, Corrado Campochiaro, Lorenzo Dagna
Pageof 14